切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2017, Vol. 06 ›› Issue (02) : 98 -101. doi: 10.3877/cma.j.issn.2095-3224.2017.02.003

所属专题: 文献

青年专家论坛

微生态制剂在结直肠外科围手术期的应用
沈通一1,(), 秦环龙1   
  1. 1. 200072 同济大学附属第十人民医院胃肠外科/同济大学医学院肠道疾病研究所
  • 收稿日期:2016-11-21 出版日期:2017-04-25
  • 通信作者: 沈通一

Application of microecological preparation in perioperative period of colorectal surgery

Tongyi Shen1,(), Huanlong Qin1   

  1. 1. Department of GI Surgery, Shanghai Tenth People′s Hospital Affiliated to Tongji University/Research Institute for Intestinal Diseases of Tongji University School of Medicine, Shanghai 200072, China
  • Received:2016-11-21 Published:2017-04-25
  • Corresponding author: Tongyi Shen
  • About author:
    Corresponding author: Shen Tongyi, Email:
引用本文:

沈通一, 秦环龙. 微生态制剂在结直肠外科围手术期的应用[J/OL]. 中华结直肠疾病电子杂志, 2017, 06(02): 98-101.

Tongyi Shen, Huanlong Qin. Application of microecological preparation in perioperative period of colorectal surgery[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(02): 98-101.

结直肠癌患者围手术期使用微生态制剂已经越来越受到重视。目前认为微生态制剂具有改善肠道菌群,保护肠屏障,减少术后感染,改善围手术期胃肠功能及生活质量等作用,对疾病的治疗进程及预后具有重要意义。今后应该加强围手术期应用微生态制剂的临床研究,为进一步推广实施建立循证基础。

Perioperative use of microbial agents in colorectal cancer patients have been paid more and more attention recently. It is thought that microecological preparation has the functions of improving intestinal flora, protecting intestinal barrier, reducing postoperative infection, improving perioperative gastrointestinal function and quality of life, and is of great significance to the treatment process and prognosis. In the future, we should strengthen the clinical research of perioperative application of probiotics and establish the evidence-based basis for the further popularization and implementation of microecological preparations.

[1]
Peitsidou K, Karantanos T, Theodoropoulos GE. Probiotics, prebiotics, synbiotics: is there enough evidence to support their use in colorectal cancer surgery? [J]. Dig Surg, 2012, 29(5):426-438.
[2]
Thomas LV, Ockhuizen T. New insights into the impact of the intestinal microbiota on health and disease: a symposium report [J]. Br J Nutr, 2012, 107(Suppl 1):S1.
[3]
Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system [J]. JAMA Intern Med, 2013, 173(22):2039-2046.
[4]
Kinross JM, Markar S, Karthikesalingam A, et al. A meta-analysis of probiotic and synbiotic use in elective surgery: does nutrition modulation of the gut microbiome improve clinical outcome? [J]. JPEN J Parenter Enteral Nutr, 2013, 37(2):243-253.
[5]
Liu Z, Li C, Huang M, et al. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and doubleblind randomized clinical trial [J]. BMC Gastroenterol, 2015, 15(1):34.
[6]
Wu XD, Liu MM, Liang X, et al. Effects of perioperative supplementation with pro-/synbiotics on clinical outcomes in surgical patients: A meta-analysis with trial sequential analysis of randomized controlled trials [J]. ClinNutr, 2016, S0261-5614.
[7]
Arumugam S, Lau CS, Chamberlain RS. Probiotics and Synbiotics Decrease Postoperative Sepsis in Elective Gastrointestinal Surgical Patients: a Meta-Analysis [J]. J GastrointestSurg, 2016, 20(6):1123-1131.
[8]
Correia MI, Liboredo JC, Consoli ML. The role of probiotics in gastrointestinal surgery [J]. Nutrition, 2012, 28(3):230-234.
[9]
Ohigashi S, Sudo K, Kobayashi D, et al. Significant changes in the intestinal environment after surgery in patients with colorectal cancer [J]. J GastrointestSurg , 2013, 17(9):1657-1664.
[10]
Komatsu S, Sakamoto E, Norimizu S, et al. Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery: a randomized controlled trial [J]. Surg Today, 2016, 46(4):479-490.
[11]
Mizuta M, Endo I, Yamamoto S, et al. Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery, inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: a prospective, randomized clinical trial [J]. Biosci Microbiota Food Health, 2016, 35(2):77-87.
[12]
Sagar S, Morgan ME, Chen S, et al. Bifidobacteriumbreve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma [J]. Respir Res, 2014, 15:46.
[13]
Eguchi S, Takatsuki M, Hidaka M, et al. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study [J]. Am J Surg, 2011, 201(4):498-502.
[14]
Chen HQ, Yang J, Zhang M, et al. Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice [J]. Am J PhysiolGastrointest Liver Physiol, 2010, 299(6):G1287-1297.
[15]
Sommacal HM, Bersch VP, Vitola SP, et al. Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial [J]. Nutr Cancer, 2015, 67(3):457-462.
[16]
Reddy BS, Macfie J, Gatt M, et al. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy [J]. Br J Surg, 2007, 94(5):546-554.
[17]
Liu ZH, Huang MJ, Zhang XW, et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial [J]. Am J ClinNutr, 2013, 97(1):117-126.
[18]
Yang Y, Xia Y, Chen H, et al. The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial [J]. Oncotarget , 2016, 7(7):8432-8440.
[19]
Ohigashi S, Hoshino Y, Ohde S, et al. Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer [J]. Surg Today, 2011, 41(9):1200-1206.
[20]
Pellino G, Sciaudone G, Candilio G, et al.Early postoperative administration of probiotics versus placebo in elderly patients undergoing elective colorectal surgery: a double-blind randomized controlled trial [J]. BMC Surg, 2013, 13(Suppl 2):S57.
[21]
Van den Nieuwboer M, Claassen E, Morelli L, et al. Probiotic and synbiotic safety in infants under two years of age [J]. Benef Microbes, 2014, 5(1):45-60.
[1] 李友, 唐林峰, 杜伟伟, 刘海亮, 余新水, 沈佳宇, 巨积辉. 皮瓣联合掌长肌腱折叠单排三点式固定治疗指背侧创面伴锤状指畸形的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 485-490.
[2] 宋玟焱, 杜美君, 陈佳丽, 石冰, 黄汉尧. 唇腭裂手术围手术期疼痛管理的研究进展及基于生物材料治疗新方法的展望[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 397-405.
[3] 刘敏, 唐恩溢, 刘喆, 葛苏蒙, 刘梅, 孙国文. 计算机导航技术在口腔颌面部微小异物取出手术中的应用[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 375-379.
[4] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[5] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[6] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[7] 刘卓, 张宗明, 张翀, 刘立民, 赵月, 齐晖. 腹腔镜手术治疗高龄急性梗阻性化脓性胆管炎患者的安全性与术式选择[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 795-800.
[8] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[9] 王妍, 李征, 卓奇峰, 周陈杰, 吉顺荣, 徐晓武, 陈洁, 虞先濬. 微小无功能性胰腺神经内分泌瘤外科治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 607-614.
[10] 雷永琪, 刘新阳, 杨黎渝, 铁学宏, 俞星新, 耿志达, 刘雨, 陈政良, 惠鹏, 梁英健. 肝脏血管周上皮样细胞肿瘤合并贫血一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 710-718.
[11] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[12] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[13] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[14] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[15] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?